Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
LipidMarine is a line of premium fish oil dietary supplement ingredients developed by the Norwegian company Pharma Marine AS. Launched in 2011, the product line is derived from sustainable anchovy and sardine biomass and is certified by Friend of the Sea. The active components are the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). These fatty acids function as nutritional support for cardiovascular health, cognitive function, and anti-inflammatory processes by modulating lipid metabolism and inflammatory signaling pathways. LipidMarine is marketed as a high-quality bulk ingredient for the global nutraceutical industry rather than a finished pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on LipidMarine.